1 / 71

JULIAN WRIGHT Consultant Nephrologist Manchester Royal Infirmary

Renal Failure – Acute and Chronic. JULIAN WRIGHT Consultant Nephrologist Manchester Royal Infirmary. Acute renal failure – hard to define. Acute renal failure – not hard to recognise. Definition of Acute Renal Failure. No agreed definitions UKRA Guidelines:

aretha
Télécharger la présentation

JULIAN WRIGHT Consultant Nephrologist Manchester Royal Infirmary

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Renal Failure – Acute and Chronic JULIAN WRIGHT Consultant Nephrologist Manchester Royal Infirmary

  2. Acute renal failure – hard to define

  3. Acute renal failure – not hard to recognise

  4. Definition of Acute Renal Failure • No agreed definitions • UKRA Guidelines: “Decline of renal excretory function over hours or days …recognized by the rise in serum urea and creatinine” • Liano et al, KI 50:811(1996) >177 µmol/L • Doubling of serum creatinine • Use of Renal Replacement Therapy

  5. Acute vs Chronic Renal Failure • Anaemia • Renal size • Tolerance of severe uraemia • Metabolic bone disease • hypocalcaemia • secondary hyperparathyroidism

  6. Diagnosis of Acute Renal Failure • History and examination • Routine bloods • Extra bloods – bicarbonate, CK, CRP + blood cultures • ECG • CXR • GN screen - immunology, dipstick urine • Renal USS • Biopsy

  7. The renal ‘troponin’ • Cystatin C endogenous cysteine proteinase inhibitor stable and constant rate of production by all nucleated cells freely filtered by glomerulus not secreted by tubules increases 2-3 days prior to creatinine

  8. The renal ‘troponin’ • Urinary excretion of kidney injury molecule-1 neutrophil gelatinase associated lipocalcin IL-18

  9. ARF: causesLiano et al, 1996 Acute tubular necrosis 45% Prerenal 21% Acute on chronic renal failure 13% Obstructive 10% Glomerulonephritis (primary & secondary) 3% Acute tubulointerstitial nephritis 2% Vasculitis 1.5% Vascular 1% Other 3.5%

  10. Acute renal failure – Rasmusan, 1982

  11. Classification of Acute Renal Failure The Undergraduate Classification works fine! Pre Renal = Circulatory Failure = “Shock” Renal = The cells of the kidney Post Renal = Obstruction

  12. Pre-renal Acute Renal Failure • Volume depletion • Decreased effective blood flow • Renal vasoconstriction • Altered intra-renal haemodynamics • Increased renal vein pressure

  13. Urine electrolytes in Pre-renal ARF Avid Na & H2O reabsorption Osmolality > 600 Na < 20mmol/l

  14. Urine electrolytes in ATN Impaired Na & H2O reabsorption Osmolality < 400 Na > 20mmol/l

  15. Intrinsic Acute Renal Failure • Acute tubular necrosis • Acute interstitial nephritis • Acute glomerulonephritis • Acute vascular syndromes • Intratubular obstruction

  16. ARF - management • Calcium gluconate – 10mls 10% (20-30 mins) • Insulin dextrose – 10 units Humulin S in 50ml 50% glucose over 10 minutes • Salbutamol nebs 2.5mls 2hrly • Get the ‘fluid balance’ right • Remove causes – drugs, sepsis • Furosemide • Calcium resonium (4-6 hours to work) • Laxatives • Bicarbonate • Renal replacement therapy

  17. ARF managementFluids Examine the patient – fluid status • Replace deficits • Balance I & O • Account for insensible losses • Leave sufficient volume space for Rx and nutrition.

  18. Furosemide • Loop diuretic – decrease oxygen consumption by decreasing Na transport – less ischaemic injury • Increases urinary flow – reduce intratubular obstruction and backleak of filtrate • Help with fluid management

  19. Furosemide • Does not prevent ARF post cardiac surgery • Increases risk of ARF when given to prevent contrast nephropathy • Mannitol – osmotic diuretic • Decreases cell swelling, scavenge free radicals, induce intrarenal prostaglandin – renal vasodilatation

  20. Dopamine • Synthesised in proximal tubular cells from L-Dopa • DA-1 receptor in vasculature and proximal and basolateral proximal tubular membranes cause renal vasodilatation and decreased Na tubular reabsorption • DA-2 receptor less sensitive to dopamine – sympathetic nerve terminals innervating blood vessels

  21. Dialysis in acute renal failure • Start HD/CVVH: • if established oliguria is present • if any (serious) complications of uraemia are present • refractory hyperkalaemic • refractory acidosis • if (serious) fluid overload is present • if serum urea >50 mmol/l (?)

  22. Advantages of IHD • Rapid solute removal • Rapid volume removal • Effective for some drug intoxications • Rapid correction of electrolytes disturbances

  23. Advantages of continuous RRT • Slower volume removal – greater haemodynamic stability • Absence of volume or solute fluctuation over time

  24. Summary Acute Renal Failure • Common • Serious • Work out the causes and consequences • Treatment is logical in many cases – and reduces mortality • Early organ support • If it could be supplied IHD may be as good in ICU setting

  25. Complications of chronic kidney disease

  26. Stages of CKD

  27. Malnutrition Inflammation Atherosclerosis Syndrome UREMIA Infection Inflammation Fluid Overload Hypertension High CRP Acute Phase response CYTOKINES Congestive Heart failure High fibrinogen High Lp(a) Low albumin Athero sclerosis Malnutrition DEATH Bergstrom and Lindholm AJKD 1998

  28. Complications • Hypertension • Left ventricular hypertrophy • Anaemia • Renal bone disease • Acidosis • Cardiovascular co-morbidity and death

  29. Hypertension and CKD: NEOERICA % Stage1 Stage2 Stage3 Stage4 Stage5 GFR60 GFR<60

  30. Blood Pressure and Progression of CKDAIPRD Study Group 1860 patients with non-diabetic kidney disease Meta-analysis of 11 RCTs of ACEIs RR Systolic BP (mmHg) Jafar et al, Ann Intern Med 2003;139:244-252

  31. Blunting of nocturnal ‘dipping’ in BPFarmer, Goldsmith, NDT 1997

  32. Hypertension • Causes of hypertension in CKD Salt and water overload Activated RAA system • Life-style management • Drugs A B C D • Blockade of renin-angiotensin system

  33. REIN STUDY

  34. Proteinuria is strongly associated with renal progression R20.06,-0.25,p<0.001

  35. Left ventricular hypertrophy • Causes Concentric LVH – hypertension Eccentric LVH – fluid overload, anaemic LV dilatation – maladaptive

  36. Left Ventricular Hypertrophy(Prevalence)

  37. Chalk Cheese

  38. Anaemia Targets • Patients with CRF should achieve Hb > 10g/dL within 6 months of seeing a nephrologist • Serum ferritin > 100µg/l (transferrin saturation >20%)

  39. Anaemia • Causes • Iron deficiency Erythropoietin deficiency GI blood loss Malnutrition Hepcidin – affects iron metabolism • Effect on patients quality of life

More Related